financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Beam Therapeutics Gets FDA Regenerative Medicine Status for BEAM-101 to Treat Sickle Cell Disease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Beam Therapeutics Gets FDA Regenerative Medicine Status for BEAM-101 to Treat Sickle Cell Disease
Aug 14, 2025 5:16 AM

07:50 AM EDT, 08/14/2025 (MT Newswires) -- Beam Therapeutics ( BEAM ) said Thursday the US Food and Drug Administration has granted regenerative medicine advanced therapy (RMAT) designation to BEAM-101, an investigational genetically modified cell therapy for the treatment of sickle cell disease.

The company said that this designation is designed to support the development and evaluation of regenerative medicines, including genetic therapies, with the intent of addressing serious or life-threatening diseases that have unmet medical needs.

Beam Therapeutics ( BEAM ) shares were up 3.3% in recent premarket activity Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
 Beone Medicines Insider Sold Shares Worth $830,360, According to a Recent SEC Filing
Beone Medicines Insider Sold Shares Worth $830,360, According to a Recent SEC Filing
Jun 25, 2025
05:21 PM EDT, 06/25/2025 (MT Newswires) -- John Oyler, Director, Chief Executive Officer, on June 23, 2025, sold 3,174 shares in Beone Medicines ( ONC ) for $830,360. Following the Form 4 filing with the SEC, Oyler has control over a total of 54,229,075 common shares of the company, with 8,173,759 shares held directly and 46,055,316 controlled indirectly. SEC Filing:...
 Tractor Supply Insider Sold Shares Worth $3,001,390, According to a Recent SEC Filing
Tractor Supply Insider Sold Shares Worth $3,001,390, According to a Recent SEC Filing
Jun 25, 2025
05:20 PM EDT, 06/25/2025 (MT Newswires) -- Jonathan S Estep, Executive Vice President, Chief Merchandise Officer, on June 23, 2025, sold 56,630 shares in Tractor Supply ( TSCO ) for $3,001,390. Following the Form 4 filing with the SEC, Estep has control over a total of 75,441 common shares of the company, with 74,605 shares held directly and 835 controlled...
 Wesdome Gold Mines Providing Kiena Exploration Update
Wesdome Gold Mines Providing Kiena Exploration Update
Jun 25, 2025
05:21 PM EDT, 06/25/2025 (MT Newswires) -- Wesdome Gold Mines Ltd. ( WDOFF ) after trade Wednesday provided a comprehensive update on its underground exploration activities at its wholly-owned Kiena mine in Val-d'Or, Quebec. Among highlights, it reported high grade mineralization Including 2,349.9 g/t gold (uncut) over 2.9 metres (core length). Anthea Bath, President and Chief Executive Officer, in a...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved